Patent application number | Description | Published |
20130310823 | Endovascular Catheters and Methods for Carotid Body Ablation - Systems, devices, and methods for treating a patient having a sympathetically mediated disease associated at least in part with augmented peripheral chemoreflex or heightened sympathetic activation. The treatments include ablating one or more peripheral chemoreceptors or associated afferent nerves to reduce or remove afferent neural signals from the peripheral chemoreceptor. | 11-21-2013 |
20130324987 | Methods and Devices for Cryogenic Carotid Body Ablation - Methods and cryogenic devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via carotid body ablation. | 12-05-2013 |
20130324989 | Percutaneous Methods and Devices for Carotid Body Ablation - Methods and percutaneous devices for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via percutaneous carotid body ablation. | 12-05-2013 |
20140005706 | Carotid Body Ablation Via Directed Energy | 01-02-2014 |
20140018788 | Devices and Systems for Carotid Body Ablation - Methods and endovascular catheters for assessing, and treating patients having sympathetically mediated disease, involving augmented peripheral chemoreflex and heightened sympathetic tone by reducing chemosensor input to the nervous system via transmural carotid body ablation. | 01-16-2014 |
20140243809 | ENDOVASCULAR CATHETERS FOR TRANS-SUPERFICIAL TEMPORAL ARTERY TRANSMURAL CAROTID BODY MODULATION - Methods, devices, and systems for carotid body modulation via accessing a target site with an endovascular approach through a superficial temporal artery. | 08-28-2014 |
Patent application number | Description | Published |
20080221567 | ELECTROSURGICAL TISSUE REMOVAL WITH A SELECTIVELY INSULATED ELECTRODE - An electrosurgical device includes an elongated body including a proximal end and a distal end and defining a longitudinal axis, at least one arm coupled to the distal end of the elongated body and an electrode coupled to at least one arm. The electrode includes an upper surface and a lower surface. The lower surface is substantially convex and defines a radius of curvature relative to an axis substantially perpendicular to the longitudinal axis. | 09-11-2008 |
20080269852 | Methods and Apparatus for Thermal Regulation of a Body - A thermal regulation system includes a thermal exchange collar for application to a neck of a patient, a thermal regulation pad for application to a body region, such as an axilla region of the patient, and a thermal regulation cap for application to a head of the patient. | 10-30-2008 |
20100137951 | METHOD AND APPARATUS FOR REDUCING BODY TEMPERATURE OF A SUBJECT - A cooling system includes a console and a tissue cooling device such as a head-cooling device. An operator applies the head-cooling device to the head of a patient at risk for ischemic injury. The console provides a cooling fluid to a fluid circulation space located between the cooling device and the patient's head under a positive gage pressure. Direct contact between the cooling fluid and the patient's head provides a relatively rapid induction of systemic hypothermia in the patient, thereby minimizing or preventing ischemic injury in the patient. The console also removes air from a channel disposed about an inner rim of the cooling device, using a negative gage pressure. Such removal of the air from the channel seals the rim of the cooling device to the head of the patient, including portions of the channel in contact with hair of the patient's head, and minimizes leaking of the cooling fluid beyond the rim of the cooling device. | 06-03-2010 |
20110251582 | LOCALIZED DELIVERY OF DRUG AGENTS - Medical devices including a substrate that are expandable from a compressed state to an expanded state; a coating on the substrate, the coating having a drug agent incorporated therein; and a sheath over the coating. The sheath is expandable from a compressed state to an expanded state and has at least one perforation therein. The medical devices are configured such that when the substrate is in a compressed state, the sheath is also in a compressed state and the perforation is substantially closed. When the substrate is in an expanded state, the sheath is also in an expanded state and the perforation is substantially open. The invention also includes a method of using the medical devices for the controlled, localized delivery of a drug agent to a target location within a mammalian body. | 10-13-2011 |
20120310159 | LOCALIZED DELIVERY OF DRUG AGENTS - Medical devices including a substrate that are expandable from a compressed state to an expanded state; a coating on the substrate, the coating having a drug agent incorporated therein; and a sheath over the coating. The sheath is expandable from a compressed state to an expanded state and has at least one perforation therein. The medical devices are configured such that when the substrate is in a compressed state, the sheath is also in a compressed state and the perforation is substantially closed. When the substrate is in an expanded state, the sheath is also in an expanded state and the perforation is substantially open. The invention also includes a method of using the medical devices for the controlled, localized delivery of a drug agent to a target location within a mammalian body. | 12-06-2012 |
Patent application number | Description | Published |
20120008624 | SYSTEMS AND METHODS FOR IMPLEMENTING A PROTOCOL-AWARE NETWORK FIREWALL - A method may include receiving a first packet; determining, in a first processor, whether the first packet meets a criterion to be forwarded to a destination indicated in the first packet; receiving a second packet; determining whether the second packet is of a type for changing the criterion and sending the second packet to a second processor if the second packets is of the type for changing the criterion; receiving instructions, based on the second packet sent to the second processor, to change the criterion; and changing the criterion. | 01-12-2012 |
20120069135 | SYSTEMS AND METHODS FOR ERROR RESILIENCE AND RANDOM ACCESS IN VIDEO COMMUNICATION SYSTEMS - Systems and methods for error resilient transmission and for random access in video communication systems are provided. The video communication systems are based on single-layer, scalable video, or simulcast video coding with temporal scalability, which may be used in video communication systems. A set of video frames or pictures in a video signal transmission is designated for reliable or guaranteed delivery to receivers using secure or high reliability links, or by retransmission techniques. The reliably-delivered video frames are used as reference pictures for resynchronization of receivers with the transmitted video signal after error incidence and for random access. | 03-22-2012 |
20120072499 | SYSTEM AND METHOD FOR THE CONTROL AND MANAGEMENT OF MULTIPOINT CONFERENCE - Systems and methods for the control and management of multipoint conferences are disclosed herein, where endpoints can selectively and individually manage the streams that will be transmitted to them. Techniques are described that allow a transmitting endpoint to collect information from other receiving endpoints, or aggregated such information from servers, and process them into a single set of operating parameters that it then uses for its operation. Algorithms are described for performing conference-level show, on-demand show, show parameter aggregation and propagation, propagation of notifications. Parameters identified for describing sources in show requests include bit rate, window size, pixel rate, and frames per second. | 03-22-2012 |
20120192240 | PARTICIPANT AWARE CONFIGURATION FOR VIDEO ENCODER - Systems and methods for multipoint video distribution are disclosed herein. In some embodiments, system for multipoint video distribution include at least one endpoint including a EECM and a DECM, and at least one server including a SECM, the server being coupled to the endpoint. In some embodiments, methods for configuring an encoder include receiving at least one property related to a capability of a decoder, determining a number of layers to be coded by the encoder, and configuring the encoder based on that at least one property. | 07-26-2012 |
20120230429 | RENDER-ORIENTATION INFORMATION IN VIDEO BITSTREAM - Disclosed are techniques for creating, coding, decoding, and using, rotation information related to one or more coded pictures in non-normative parts of a coded video bitstream. | 09-13-2012 |
20130250037 | System and Method for the Control and Management of Multipoint Conferences - Systems and methods for the control and management of multipoint conferences are disclosed herein, where endpoints can selectively and individually manage the streams that will be transmitted to them. Techniques are described that allow a transmitting endpoint to collect information from other receiving endpoints, or aggregated such information from servers, and process them into a single set of operating parameters that it then uses for its operation. Algorithms are described for performing conference-level show, on-demand show, show parameter aggregation and propagation, propagation of notifications. Parameters identified for describing sources in show requests include bit rate, window size, pixel rate, and frames per second. | 09-26-2013 |
20130322553 | Systems And Methods For Error Resilience In Video Communication Systems - Systems and methods for error resilient transmission and for random access in video communication systems are provided. The video communication systems are based on single-layer, scalable video, or simulcast video coding with temporal scalability, which may be used in video communication systems. A set of video frames or pictures in a video signal transmission is designated for reliable or guaranteed delivery to receivers using secure or high reliability links, or by retransmission techniques. The reliably-delivered video frames are used as reference pictures for resynchronization of receivers with the transmitted video signal after error incidence and for random access. | 12-05-2013 |
20150264378 | Systems And Methods For Error Resilience And Random Access In Video Communication Systems - Systems and methods for error resilient transmission and for random access in video communication systems are provided. The video communication systems are based on single-layer, scalable video, or simulcast video coding with temporal scalability, which may be used in video communication systems. A set of video frames or pictures in a video signal transmission is designated for reliable or guaranteed delivery to receivers using secure or high reliability links, or by retransmission techniques. The reliably-delivered video frames are used as reference pictures for resynchronization of receivers with the transmitted video signal after error incidence and for random access. | 09-17-2015 |
Patent application number | Description | Published |
20080255063 | 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF - The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds. | 10-16-2008 |
20100261667 | 3- -D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF - The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds. | 10-14-2010 |
20110275589 | 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF - The invention is directed to 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and pharmaceutical compositions containing them, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds and prodrugs. | 11-10-2011 |
20120121541 | 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-D]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF - The invention is directed to 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and pharmaceutical compositions containing them, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds and prodrugs. | 05-17-2012 |
20130259831 | 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-Oxazolo and 3H-Thiazolo[4,5-d]pyrimidin-2-one Compounds and Prodrugs Thereof - The invention is directed to 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and pharmaceutical compositions containing them, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds and prodrugs. | 10-03-2013 |
Patent application number | Description | Published |
20100125065 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS - In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention. | 05-20-2010 |
20100179132 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS - In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing plasma and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention. | 07-15-2010 |
20110160190 | CARBOLINE DERIVATIVES USEFUL IN THE INHIBITION OF ANGIOGENESIS - In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the treatment of solid tumor cancer, and in reducing plasma and/or tumor VEGF levels, are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the treatment of cancer, and the reduction of plasma and/or tumor VEGF levels, using the compounds of the invention. | 06-30-2011 |